title: Systemic administration of the PGE-1 analogue alprostadil for prophylaxis of early kidney graft failure.
authors.affiliation: Nephrology and Renal Transplant Unit, Niguarda-Ca' Granda Hospital, Milano, Italy.
authors.forename: M L
authors.initials: ML
authors.lastname: Broggi
authors.forename: B
authors.initials: B
authors.lastname: Brando
authors.forename: G
authors.initials: G
authors.lastname: Civati
authors.forename: C
authors.initials: C
authors.lastname: Brunati
authors.forename: G
authors.initials: G
authors.lastname: Busnach
authors.forename: A
authors.initials: A
authors.lastname: Sperandeo
authors.forename: M
authors.initials: M
authors.lastname: Seveso
authors.forename: L
authors.initials: L
authors.lastname: Minetti
mesh_terms: D058186:Acute Kidney Injury / Q000188:drug therapy / Q000517:prevention & control; D000328:Adult; D000527:Alprostadil / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D016030:Kidney Transplantation
chemical_list: D000527:Alprostadil